IIR’s 2nd Annual Value-Driven Pharma event is the only conference that delivers the tools and the know how pharmaceutical executives need to meet payers increasingly strict criteria for coverage and reimbursement. No other managed market event offers wider accents to industry experts and solutions.
Obtain the tools to deliver solid economic health data applicable to real-world needs and decisions faced by patients, clinicians, and payers necessary to obtain formulary placement.
Respond to the shifting payer mix and optimize your formulary and reimbursement strategy to ensure you reap the benefits of increased prescription volumes.
This is the last week to save, so register now for Value-Driven Pharma to navigate the changing reimbursement paradigm to ensure your product’s value is undisputable.
We know that budgets are tight and it can be difficult to get time away from the office – however, we continue to hear from the industry that it is more important than ever to gain insights from industry thought leaders speaking at Value- Driven Pharma.
To learn more about this year’s agenda and impressive speaker line-up, download the brochure or visit our website. We are confident that once you do, you and your team will discover that Value-Driven Pharma is a can’t-miss event for 2010.
About Us
Health Care Insights - From Policy to Practice is the trusted source for news and commentary from the nation's leading Health Care Events such as Medicaid Drug Rebate Program Summit (MDRP), Medicaid Managed Care Congress (MMCC), FDA/CMS to inform Health Plans and Pharmaceutical Manufacturers on the latest developments on Medicare, Medicaid Managed Care, Government Programs, and Health Insurance Exchanges.
Topics we cover include reform, best business practices, the latest innovations, and novel payment models.
Subscribe
Blog Archive
-
▼
2010
(111)
-
▼
August
(14)
- HealthSpring becomes 7th largest Medicare Advantag...
- Seniors will see a gap closing in the doughnut hole
- Some physicians leaving Medicare due to costs
- What effect will Avastin's fate have on healthcare?
- Pharma and Health Plan executives debate criteria ...
- MDRP 2010: Attending Companies to Date
- Overspending on many drugs in Medicaid
- Doctors not taking full advantage of ePrescribing
- IIR Announces Healthcare Reform Forum Program, Dat...
- Missouri votes against part of health care reform
- Medicare funds should be extended
- White Paper: Pharmaceutical Marketing in Perspecti...
- ePrescribing among physicians is limited
- Obama administration sees savings in healthcare now
-
▼
August
(14)
No comments:
Post a Comment